Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says - 2The most effective method to Recuperate After a Dental Embed Strategy: A Far reaching Guide
- 3Native Americans had dice and games of probability long before other cultures, study finds
- 4Arctic sea ice hits lowest winter level as unprecedented heat hits smashes records all over Earth
- 5Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25
- Iran plans new restrictions in overhaul of Strait of Hormuz rules
- Astronauts on the ISS watched NASA's historic Artemis 2 launch from space
- Viable Tips for Seniors to Purchase a Minimal expense Jeep Wrangler
- Vote in favor of your Favored kind of pasta
- French rapper Gims placed under investigation for 'aggravated money laundering'
- The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise...
- Carnival fever hits Lagos as locals celebrate Afro-Brazilian heritage
- First part of major new German-Danish tunnel cleared for lowering
- Golan resident convicted of spying for Iran after passing tank movement, missile-impact data
